RSV vaccine
Adults 60 years of age and older
AREXVY is a new vaccine recently approved by Health Canada for the prevention of lower respiratory tract disease (LRTD) caused by RSV in people 60 years of age and older. Following direction from the Ontario Ministry of Health, Ontario is rolling out a publicly funded vaccination program for eligible people (i.e., 60+) living in long-term care homes, Elder Care Lodges, and some retirement homes. Anyone who is 60 years of age or older and not eligible for the publicly funded vaccine can speak to their healthcare provider about receiving the RSV vaccine through private purchase.
If you are eligible for publicly funded AREXVY, please get vaccinated as soon as possible. The National Advisory Committee on Immunization (NACI) has not yet provided recommendations on the broader use of this vaccine.
AREXVY is given as a single dose. A 14 day period is needed between receiving AREXVY and another vaccine, such as COVID-19 and flu.
Talk to your Healthcare Provider
Always tell your healthcare provider if you have allergies or if you have had side effects from a vaccine in the past. Postpone vaccination if you are ill or have a fever. Check with your healthcare provider to find out if the RSV vaccine is right for you.
Where to get an RSV vaccine
Residents of Ontario long-term care homes, Elder Care Lodges, and some retirement homes who are 60 years of age and older will be offered the publicly funded AREXVY vaccine through their home/Lodge when the vaccine is available and should get vaccinated as soon as possible.
The publicly funded AREXVY vaccine is not currently provided by pharmacies or through Public Health.